NCT04300985View on ClinicalTrials.gov

Magnesium Sulfate Versus Dexmedetomidine on Anesthesia Awakening.

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions
Cholecystectomy
Interventions
DRUG

Dexmedetomidine

Patients will start receiving dexmedetomidine 15 minutes before general anesthetic induction.

DRUG

Sham treatment

Patients will start receiving saline solution infusion 15 minutes before general anesthetic induction.

DRUG

Magnesium Sulfate

Patient will start receiving magnesium infusion (20 mg/kg/h) 15 minutes before general anesthetic induction.

Trial Locations (1)

01246-903

Hospital das Clínicas - Faculdade de Medicina da Universidade de Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT04300985 - Magnesium Sulfate Versus Dexmedetomidine on Anesthesia Awakening. | Biotech Hunter | Biotech Hunter